NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

NCT07741968

RecruitingNA

Sponsor: City of Hope Medical Center

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma

Interventions: Best Practice, Interview, Supportive Care, Supportive Care, Supportive Care

Countries: United States

This clinical trial studies whether an intervention supported by technology (blended e-health intervention) works to improve fear of progression (FOP) in women with gynecologic or breast cancer. FOP is the fear patients experience from the possibility that their cancer could grow, spread, or get worse. Managing FOP is a leading unmet concern of cancer patients. High levels of FOP are associated with distress, depression, and increased health care costs, despite this, access to resources to address FOP remain limited. The blended e-health intervention in this trial offers remote group sessions along with online sessions to help patients access the information. Session content incorporates values-based goal setting and skills practices to manage unhelpful beliefs about worry and promote helpful coping behaviors. The sessions may help patients recognize unhelpful thoughts and behaviors which reinforce worry. A blended e-health intervention may be an effective way to improve FOP in women with gynecologic or breast cancer.

Eligibility overview

Sex: FEMALE

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Women with stage III or IV GYN (ovarian, endometrial, cervical, vulvar/vaginal) or breast cancer who are at least 2 months from initial diagnosis OR Women with stage I or II endometrial, ovarian, or breast cancer with carcinosarcoma histology OR Women with stage I or II triple negative breast cancer
* Score ≥ 34 on the Fear of Progression Short-Form, indicating dysfunctional levels
* Age 18 or older; able to read and understand English
* Patients can be on active treatment or surveillance. They can be no evidence of disease (NED), recurrent or with progressive disease

Exclusion Criteria:

* Enrolled in hospice
* Ongoing uncontrolled active psychiatric condition that, in the opinion of the investigator, would interfere in the conduct of the study (e.g., mood disorders, psychosis disorders, or substance use), Major depression as assessed by Patient Health Questionnaire-9 (PHQ-9)
* Non-English speaking
* Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)
* Current participation in a mind-body or mindfulness education program within the past six weeks
Locations (11)
  • Arcadia, California, United States
  • Duarte, California, United States
  • Huntington Beach, California, United States
  • Irvine, California, United States
  • Lancaster, California, United States
  • Long Beach, California, United States
  • Santa Clarita, California, United States
  • Simi Valley, California, United States
  • South Pasadena, California, United States
  • Upland, California, United States
  • West Covina, California, United States